Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System

计划入组 250 人 · 首次发布于 2021 年 8 月 17 日

Study of the SilverHawk™ /TurboHawk™ Plaque Excision Systems Used With SpiderFX to Treat Calcified Peripheral Arterial Disease (DEFINITIVE Ca++)

计划入组 133 人 · 首次发布于 2008 年 8 月 12 日

Cost-utility Analysis of the Outpatient Versus Conventional Hospitalization in Treatment of Occlusive Arterial Disease

计划入组 160 人 · 首次发布于 2015 年 10 月 20 日

bioengineered human acellular vessel (peripheral arterial disease)

Peripheral arterial disease cell therapy (MultiGene Vascular Systems)

liver disease program

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

CURE RARE DISEASE, INC.

United States

Amplitude Vascular Systems Enrolls First Patient in POWER PAD II Intravascular Lithotripsy Trial

IVL Shows Sustained Safety and Efficacy in Treating Calcified Nodules in Coronary Arteries

FDA Approves Abbott's Coronary IVL System Trial for Treating Calcified Coronary Artery Disease